Data catalog
MHRA paediatric investigation plans
About 1,120 records
More records
Continuing the MHRA paediatric investigation plans list, 1000 records per page, after mhra-101319-pip01-23-m01-update.
- mhra-101323-pip01-23tulisokibart
- mhra-101323-pip02-24tulisokibart
- REGADENOSON
- REGADENOSON
- mhra-101326-pip01-24Human IgG4 monoclonal antibody against BCMA and CD3
- mhra-101333-pip01-242-(3,5-dichloro-1-methyl-indazol-4-yl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl…
- mhra-101334-pip01-24Insulin Efsitora Alfa (LY3209590)
- LANDIOLOL HYDROCHLORIDE
- DENGUE VIRUS SEROTYPE 2 EXPRESSING DENGUE VIRUS SEROTYPE 1 SURFACE PROTEINS LIVE…
- DENGUE VIRUS SEROTYPE 2 EXPRESSING DENGUE VIRUS SEROTYPE 1 SURFACE PROTEINS LIVE…
- mhra-101338-pip01-24elinzanetant
- ESKETAMINE HYDROCHLORIDE
- mhra-101349-pip01-24SECUKINUMAB
- mhra-101350-pip01-24DECITABINE
- Autologous tumour-infiltrating lymphocytes (LN-144/LN-145)
- mhra-101354-pip01-24UPADACITINIB
- mhra-101355-pip01-24(3S,10S,14S)-1-[4-[[(2S)-4-carboxy-2-[(2S)-4-carboxy-2-(6-[18F]…
- mhra-101356-pip01-24inebilizumab
- mhra-101359-pip01-24spesolimab
- Purified Rabies virus, WISTAR PM/WI 38-1503-3M strain (inactivated)
- ZANAMIVIR
- FREMANEZUMAB
- mhra-101378-pip01-24UPADACITINIB
- mhra-101379-pip01-24Broadly neutralizing anti-HIV human monoclonal antibody (VH3810109)
- mhra-101384-pip01-24Telisotuzumab adizutecan
- mhra-101385-pip01-24Valemetostat tosilate
- DARIDOREXANT HYDROCHLORIDE
- DARIDOREXANT HYDROCHLORIDE
- mhra-101389-pip01-24omaveloxolone
- mhra-101392-pip01-24Influenza Virus Type A, H1N1
- mhra-101394-pip01-24clascoterone
- mhra-101395-pip01-24Zanidatamab
- mhra-101400-pip01-24nirogacestat hydrobromide
- mhra-101404-pip01-24TRASTUZUMAB DERUXTECAN
- mhra-101407-pip01-24chikungunya virus virus-like particle
- IVOSIDENIB
- mhra-101410-pip01-24ISATUXIMAB
- mhra-101411-pip01-24Erdafitinib
- mhra-101422-pip01-24Single-stranded 5' capped mRNA encoding the HAs of the influenza virus strains A/H1N1…
- mhra-101422-pip02-24single-stranded 5' capped mRNA encoding the HAs of the influenza virus strains A and B and…
- mhra-101426-pip01-24Deutetrabenazine
- mhra-101431-pip01-24SODIUM PHENYLBUTYRATE
- mhra-101435-pip01-24Hemopexin, human
- (R)-1-(1-acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1H-imidazo[4,5-c]pyridin-2(3H…
- mhra-101441-pip01-24modified recombinant version of the human myeloid-derived growth factor
- mhra-101442-pip01-24Modified messenger ribonucleic acid encoding individual patient-specific tumour…
- mhra-101445-pip01-24CANNABIDIOL
- DIFELIKEFALIN ACETATE
- mhra-101451-pip01-24Osivelotor
- Osivelotor
- mhra-101454-pip01-24Donidalorsen
- mhra-101457-pip01-24Acasunlimab
- mhra-101465-pip01-24anitocabtagene autoleucel
- mhra-101467-pip01-24apitegromab
- mhra-101468-pip01-24DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
- mhra-101469-pip01-24Garetosmab
- BELATACEPT
- mhra-101486-pip01-24Avalotcagene Ontaparvovec
- mhra-101488-pip01-24etavopivat
- mhra-101489-pip01-24Enlicitide (decanoate)
- UPADACITINIB
- mhra-101492-pip01-24Recombinant Influenza Hemagglutinin-strain A (H1N1 subtype)
- mhra-101493-pip01-24anti-alpha-synuclein recombinant humanised monoclonal antibody (Company code UCB7853)
- LUSPATERCEPT
- mhra-101495-pip01-24Split influenza virus, inactivated containing antigens equivalent to the A/H1N1-like…
- mhra-101496-pip01-24zirconium (89Zr) girentuximab senvedoxam
- mhra-101497-pip01-24laruparetigene zovaparvovec
- mhra-101499-pip01-24Zanidatamab
- mhra-101500-pip01-24Zanidatamab
- mhra-101506-pip01-24Zongertinib
- mhra-101509-pip01-24Ferric Citrate Coordination Complex
- ERTUGLIFLOZIN L-PYROGLUTAMIC ACID
- FLUTICASONE FUROATE
- ECULIZUMAB
- mhra-101521-pip01-24Derivative of 6-(piperidine-1-carbonyl)pyridine-3-ol
- mhra-101523-pip01-24Raludotatug deruxtecan
- mhra-101525-pip01-24Actinium-225-2-(4,7,10-tris-carboxymethyl-1,4,7,10 tetraaza-cyclododec-1-yl)-pentanedioic…
- mhra-101538-pip01-24NIVOLUMAB
- mhra-101540-pip01-24derivative of pyrindin-2-yl)cyclopropanecarboxamide hydrochloride
- mhra-101542-pip01-24lutikizumab
- SELUMETINIB HYDROGEN SULFATE
- mhra-101546-pip01-24SECUKINUMAB
- mhra-101547-pip01-24IgG-like T cell engager binding to DLL3 and CD3
- mhra-101548-pip01-24Xaluritamig
- mhra-101564-pip01-24(5aSa,17aRa)-20-Chloro-2-[(2S,5R)-2,5-dimethyl-4-(prop-2-enoyl)piperazin-1-yl]-14,17-diflu…
- mhra-101570-pip01-24firmonertinib
- mhra-101572-pip01-24Nogapendekin alfa
- mhra-101573-pip01-24Trofinetide
- mhra-101581-pip01-24rinatabart sesutecan
- Recombinant Varicella Zoster Virus Glycoprotein E
- mhra-101586-pip01-24Ifinatamab deruxtecan
- CEFIDEROCOL SULFATE TOSYLATE
- mhra-101588-pip01-24Derivative of 1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
- mhra-101591-pip01-24SACITUZUMAB GOVITECAN
- mhra-101595-pip01-24efinopegdutide
- Ibrexafungerp
- mhra-101602-pip01-24navepegritide
- mhra-101605-pip01-24Telisotuzumab adizutecan
- ADRENALINE
- mhra-101619-pip01-24spesolimab
- mhra-101622-pip01-24Derivative of azabicycloheptane-carboxamide
- LISOCABTAGENE MARALEUCEL
- IXEKIZUMAB
- mhra-101654-pip01-24Volrustomig
- mhra-101663-pip01-24AMIVANTAMAB
- mhra-101664-pip01-24SECUKINUMAB
- mhra-101677-pip01-24Rilvegostomig
- mhra-101680-pip01-24CICLOSPORIN
- MEPOLIZUMAB
- mhra-101690-pip01-24EMPAGLIFLOZIN
- ATOGEPANT MONOHYDRATE
- mhra-101694-pip01-24Human IgG1 monoclonal antibody targeting amyloid transthyretin
- mhra-101702-pip01-24Modified messenger ribonucleic acid encoding individual patient-specific tumour…
- IPTACOPAN HYDROCHLORIDE MONOHYDRATE
- USTEKINUMAB
- mhra-101725-pip01-24GUSELKUMAB
- mhra-101737-pip01-24GOZETOTIDE
- mhra-101746-pip01-24H-(D)p-Benzoylphenylalanyl-(D)seryl-(D)tryptophanyl-(D)seryl-(D)pentafluorophenylalanyl-(D…
- TOFACITINIB CITRATE
- Tabelecleucel
About this dataset
A paediatric investigation plan sets out the studies a company must run in children to support authorisation of a medicine in the UK, or records a waiver or deferral.
Source: UK Medicines and Healthcare products Regulatory Agency (MHRA). Contains public sector information licensed under the Open Government Licence v3.0